Research + Innovation

Research and innovation is a vital component of the Global Polio Eradication Initiative, providing the necessary evidence and tools to guide the final steps to a lasting polio-free world and beyond. The Global Polio Eradication Initiative coordinates and supports an extensive programme of research and product innovation and development from a wide range of core scientific disciplines. The research programme has two broad objectives:

Research is a vital component of the Global Polio Eradication Initiative. @ Gavi

to identify, develop and evaluate new tools and tailored approaches to assess and sensitise to ensure the impact of eradication efforts is maximised

to inform long-term policy for the post-eradication era.

Current research areas include :

  • Optimizing oral polio vaccine efficacy
  • Developing affordable inactivated polio vaccine
  • Managing risks associated with vaccine-derived polioviruses and vaccine-associated paralytic polio (including OPV cessation)
  • Antivirals
  • Polio diagnostics
  • Surveillance research

CALL FOR EXPRESSIONS OF INTEREST – Commercialization and technology transfer of Virus-Like-Particle Polio Vaccine

The World Health Organization is seeking Expressions of Interest from public- and private-sector vaccine manufacturers and other institutions on development and manufacture of affordable poliovirus virus-like-particle vaccine. Read the expression of Interest.

Related Resources